EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Blood‐Derived Factor Rescues ALS: Platelet Factor 4 Activates OPTN‐Dependent Autophagy to Clear SOD1 Aggregates Independently of PINK1

Qingjian Xie, Yanbo Zhu, Wenhua Jiang, Haobo Xie, Yaojia Li, Mengjie Hu, Kezheng Li, Huan Yu, Yixuan Pan, Chaoyi Jiang, Xueqin Song, Dongsheng Fan und 1 weitere

Advanced Science · 2026

DOI: 10.1002/advs.76778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Qingjian Xie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, First Affiliated Hospital of Wenzhou Medical University and Department of Neurology, First Affiliated Hospital…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Autophagy, Superoxide Dismutase-1, Cell Cycle Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Hebei Key Laboratory of Neurology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral factors that systemically regulate amyotrophic lateral sclerosis (ALS) have remained elusive‐until now. Here, by integrating population‐scale epidemiology with mechanistic dissection, we identify platelet factor 4 (PF4) as the central driver of a circulating neuroprotective axis that restores proteostasis and rescues ALS. In a prospective cohort of >500 000 UK Biobank participants, platelet indices were strongly associated with ALS risk, and serum PF4 levels were significantly reduced in ALS patients. Systemic administration of recombinant PF4 in hSOD1 G93A mice produced dramatic therapeutic effects: extended survival, preserved motor function, attenuated neuroinflammation, and reduced neuromuscular junction denervation. Remarkably, this efficacy appears pathology‐selective–robust in SOD1‐driven models but shows no observable effect in TDP‐43 or C9orf72 ALS models. Mechanistically, PF4 achieves what few molecules can: it engages the cell surface receptor LRP1 to activate the TBK1‐OPTN signaling axis, restoring impaired autophagic flux through a PINK1/Parkin‐independent pathway requiring ATG7, establishing a previously unrecognized peripheral platelet‐autophagy‐neuron axis that facilitates the co‐clearance of pathological SOD1 aggregates and damaged mitochondria. This study unveils PF4 as a first‐in‐class circulating autophagy regulator with therapeutic potential in ALS. Beyond identifying a candidate biomarker and drug lead, it reveals that systemic factors can directly engage central proteostatic machinery–opening a new frontier for ALS therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisAutophagySuperoxide Dismutase-1Cell Cycle ProteinsPlatelet Factor 4Protein KinasesAnimalsHumansMicePTEN-Induced Putative KinaseMaleDisease Models, AnimalFemaleMembrane Transport Proteins

Stichwörter der Autor:innen

OPTNPF4SOD1amyotrophic lateral sclerosismitophagyproteostasis

Substanzen

Superoxide Dismutase-1Cell Cycle ProteinsPlatelet Factor 4PTEN-Induced Putative KinaseProtein KinasesOPTN protein, humanSOD1 protein, humanMembrane Transport Proteins

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, First Affiliated Hospital of Wenzhou Medical University and Department of Neurology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Rehabilitation Medicine, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
  • Chinese PLA General Hospital, Beijing, China.
  • Department of Pediatrics, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Neurology and Neurological Laboratory of Hebei Province, The Second Hospital of Hebei Medical University, and Key Laboratory of Neurology (Hebei Medical University), Ministry of Education, Shijiazhuang, Ch…
  • Department of Neurology, Peking University Third Hospital, Beijing, China.

ORCID-Profile: Binbin Deng

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Hebei Key Laboratory of Neurology

Zitieren

APA

Xie, Q., Zhu, Y., Jiang, W., Xie, H., Li, Y., Hu, M., Li, K., Yu, H., Pan, Y., Jiang, C., Song, X., Fan, D., & Deng, B. (2026). A Blood‐Derived Factor Rescues ALS: Platelet Factor 4 Activates OPTN‐Dependent Autophagy to Clear SOD1 Aggregates Independently of PINK1. Advanced Science. https://doi.org/10.1002/advs.76778

Vancouver

Xie Q, Zhu Y, Jiang W, Xie H, Li Y, Hu M, et al. A Blood‐Derived Factor Rescues ALS: Platelet Factor 4 Activates OPTN‐Dependent Autophagy to Clear SOD1 Aggregates Independently of PINK1. Advanced Science. 2026. doi:10.1002/advs.76778

BibTeX
@article{Xie2026,
  author = {Xie, Qingjian and Zhu, Yanbo and Jiang, Wenhua and Xie, Haobo and Li, Yaojia and Hu, Mengjie and Li, Kezheng and Yu, Huan and Pan, Yixuan and Jiang, Chaoyi and Song, Xueqin and Fan, Dongsheng and Deng, Binbin},
  title = {A Blood‐Derived Factor Rescues ALS: Platelet Factor 4 Activates OPTN‐Dependent Autophagy to Clear SOD1 Aggregates Independently of PINK1},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76778}
}
Kostenlos starten →